Marketing-authorisation holder · Spain
Boehringer Ingelheim Espana S.A.
7 medicines in 1 country, as authorisation holder, manufacturer and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Spain
7 medicines in 1 country, as authorisation holder, manufacturer and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ATROVENT 20 microgramos SOLUCION PARA INHALACION EN ENVASE A PRESION20 µg · Solución para inhalación en envase a presión | Ipratropium bromide | Spain | Marketed | 1979 |
| ATROVENT MONODOSIS 250 mcg / 2ml SOLUCION PARA INHALACION POR NEBULIZADOR250 µg · Solución para inhalación por nebulizador | Ipratropium bromide | Spain | Marketed | 1996 |
| ATROVENT MONODOSIS 500 mcg/ 2ml SOLUCION PARA INHALACION POR NEBULIZADOR500 µg · Solución para inhalación por nebulizador | Ipratropium bromide | Spain | Marketed | 1996 |
| NOLOTIL 0,4 g/ml SOLUCION INYECTABLE Y PARA PERFUSION2 g · Solución inyectable | Dipirona | Spain | Marketed | 1965 |
| NOLOTIL 575 mg CAPSULAS DURAS575 mg · Cápsula dura | Dipirona | Spain | Marketed | 1969 |
| SINTONAL 0,25 mg comprimidos0,25 mg · Comprimido | Brotizolam | Spain | Marketed | 1989 |
| MOVALIS 15 mg/1,5 ml SOLUCION INYECTABLE15 mg · Solución inyectable | Meloxicam | Spain | Withdrawn | 2001 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 7 | 6 | 1 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.